Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy XBiotech stock | $17.23

Learn how to easily invest in XBiotech stock.

XBiotech Inc
NASDAQ: XBIT - USD
BIOTECHNOLOGY
$16.02
+$0.01 (+0.06%)

XBiotech Inc is a biotechnology business based in the US. XBiotech shares (XBIT) are listed on the NASDAQ and all prices are listed in US Dollars. XBiotech employs 95 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in XBiotech

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – XBIT – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

XBiotech stock price (NASDAQ: XBIT)

Use our graph to track the performance of XBIT stocks over time.

XBiotech shares at a glance

Information last updated 2021-07-28.
Latest market close$17.23
52-week range$14.76 - $21.48
50-day moving average $16.64
200-day moving average $17.71
Wall St. target price$18.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $16.45

Buy XBiotech shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Webull
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $3.00 and $300 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
Stocks, ETFs
N/A
$0 per month
Download and sign up with Public.com; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
0%
N/A
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Robinhood
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
Stocks, Options, ETFs
$0
$0 per year
N/A
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy XBiotech stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

XBiotech price performance over time

Historical closes compared with the close of $17.23 from 2021-05-26

1 week (2021-07-23) N/A
1 month (2021-07-02) 3.30%
3 months (2021-05-03) 0.17%
6 months (2021-01-30) N/A
1 year (2020-07-30) N/A
2 years (2019-07-30) N/A
3 years (2018-07-30) N/A
5 years (2016-07-30) N/A

XBiotech financials

Revenue TTM $36.2 million
Gross profit TTM $9.4 million
Return on assets TTM -3.44%
Return on equity TTM -3.94%
Profit margin -38.09%
Book value $11.74
Market capitalisation $487.5 million

TTM: trailing 12 months

Shorting XBiotech shares

There are currently 825,199 XBiotech shares held short by investors – that's known as XBiotech's "short interest". This figure is 8% down from 897,267 last month.

There are a few different ways that this level of interest in shorting XBiotech shares can be evaluated.

XBiotech's "short interest ratio" (SIR)

XBiotech's "short interest ratio" (SIR) is the quantity of XBiotech shares currently shorted divided by the average quantity of XBiotech shares traded daily (recently around 149492.57246377). XBiotech's SIR currently stands at 5.52. In other words for every 100,000 XBiotech shares traded daily on the market, roughly 5520 shares are currently held short.

However XBiotech's short interest can also be evaluated against the total number of XBiotech shares, or, against the total number of tradable XBiotech shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case XBiotech's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 XBiotech shares in existence, roughly 30 shares are currently held short) or 0.0455% of the tradable shares (for every 100,000 tradable XBiotech shares, roughly 46 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against XBiotech.

Find out more about how you can short XBiotech stock.

XBiotech share dividends

We're not expecting XBiotech to pay a dividend over the next 12 months.

XBiotech share price volatility

Over the last 12 months, XBiotech's shares have ranged in value from as little as $14.76 up to $21.48. A popular way to gauge a stock's volatility is its "beta".

XBIT.US volatility(beta: 1.37)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while XBiotech's is 1.37. This would suggest that XBiotech's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

XBiotech overview

XBiotech Inc. , a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of antibody therapies for treating oncology, inflammatory conditions, and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and True Human COVID-19 therapy for treating the COVID-19 mutant virus. In addition, the company provides clinical trial contract research operations to conduct two large, double-blind placebo-controlled Phase II clinical studies. The company was incorporated in 2005 and is headquartered in Austin, Texas. .

Stocks similar to XBiotech

Frequently asked questions

What percentage of XBiotech is owned by insiders or institutions?
Currently 41.397% of XBiotech shares are held by insiders and 15.409% by institutions.
How many people work for XBiotech?
Latest data suggests 95 work at XBiotech.
When does the fiscal year end for XBiotech?
XBiotech's fiscal year ends in December.
Where is XBiotech based?
XBiotech's address is: 5217 Winnebago Lane, Austin, TX, United States, 78744
What is XBiotech's ISIN number?
XBiotech's international securities identification number is: CA98400H1029
What is XBiotech's CUSIP number?
XBiotech's Committee on Uniform Securities Identification Procedures number is: 98400H102

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site